Table: Daito -2021/22 group results

Daito Pharmaceutical

14/07/2022 07:00

Jul 14 (Reuters)- 
          Daito Pharamaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              May 31, 2022    May 31, 2021   May 31, 2023     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           43.46           48.71          44.00                 
                               (+8.3 pct)     (+1.2 pct)               
  Operating        6.55            5.91           4.50                 
               (+10.9 pct)     (+10.3 pct)    (-31.3 pct)              
  Recurring        6.73            6.07           4.60                 
               (+10.9 pct)     (+11.1 pct)    (-31.6 pct)              
  Net
  Net              4.67            4.25           3.20                 
               (+9.9 pct)      (+7.6 pct)     (-31.5 pct)              
  EPS          335.41 yen      311.02 yen     222.72 yen               
  Ann Div       60.00 yen       46.00 yen      60.00 yen               
  -Q2 Div       25.00 yen       23.00 yen      30.00 yen               
  -Q4 Div       35.00 yen       23.00 yen      30.00 yen               
  
  NOTE - Daito Pharamaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T